AbbVie announces 380 million dollar investment to expand Illinois manufacturing capacity
The drugmaker will build two new facilities in North Chicago. This expansion aims to boost production of key medicines following new U.S. import tariffs.
Insights:
AbbVie Inc. announced a $380 million investment today to build two active pharmaceutical ingredient (API) manufacturing facilities at its North Chicago, Illinois campus. The project is intended to expand domestic production capacity within the US 
US for neuroscience and obesity medicines, as well as the company’s future pipeline of treatments.
US for neuroscience and obesity medicines, as well as the company’s future pipeline of treatments.
